Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COCA COLA COKO · Entity 2806 | Director | April 01, 2024 | April 03, 2024 |
| COLGATE PALMOLIVE COCL · Entity 2972 | Director | April 01, 2021 | April 05, 2021 |
| GoHealth, Inc.GOCO · Entity 22896 | Director | September 14, 2021 | September 16, 2021 |
| Organon & Co.OGN · Entity 4115 | Director | June 12, 2026 | June 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COCA COLA CO
Report date April 01, 2024 · Filed April 03, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Share UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 61,143.8912 |
Reported balance
After 2024-04-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-04-01 · Grant · Acquired 3,280.3018 · Balance 61,143.8912 F1: Each phantom share unit is economically equivalent to one share of Common Stock. F2: Phantom share units credited to the reporting person under The Coca-Cola Company Directors' Plan effective January 1, 2020 (the "Directors' Plan") for 2024 compensation, which may include voluntary deferred compensation. F3: The phantom share units credited under the Directors' Plan are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board. F4: This number includes phantom share units accrued through April 1, 2024 under the Directors' Plan as a result of crediting phantom dividends. |
| Common Stock, $.25 Par ValueSEC Table I · non-derivative | Direct | 3,000 |
Reported balance
Holding disclosure · report date 2024-04-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 3,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Each phantom share unit is economically equivalent to one share of Common Stock.
F2: Phantom share units credited to the reporting person under The Coca-Cola Company Directors' Plan effective January 1, 2020 (the "Directors' Plan") for 2024 compensation, which may include voluntary deferred compensation.
F3: The phantom share units credited under the Directors' Plan are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board.
F4: This number includes phantom share units accrued through April 1, 2024 under the Directors' Plan as a result of crediting phantom dividends.
COLGATE PALMOLIVE CO
Report date April 01, 2021 · Filed April 05, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,063 |
Reported balance
After 2021-04-01 transaction · row 1
1 source rowRow 1 · 2021-04-01 · Grant · Acquired 228 · Balance 21,063 F1: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 19,689 |
Reported balance
Holding disclosure · report date 2021-04-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 19,689 |
Filing footnotes · ownership attribution and instrument terms
F1: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.
GoHealth, Inc.
Report date September 14, 2021 · Filed September 16, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 12,831 |
Reported balance
After 2021-09-14 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-09-14 · Grant · Acquired 5,688 · Balance 12,831 F1: Each deferred stock unit represents the right to receive one share of Class A common stock of the Issuer. F2: The deferred stock units vest in four quarterly installments, with the first such quarterly installment vesting on December 14, 2021, and will be settled in shares of the Issuer's Class A common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Directors Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Each deferred stock unit represents the right to receive one share of Class A common stock of the Issuer.
F2: The deferred stock units vest in four quarterly installments, with the first such quarterly installment vesting on December 14, 2021, and will be settled in shares of the Issuer's Class A common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Directors Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.
Organon & Co.
Report date June 12, 2026 · Filed June 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 81,141.134 |
Reported balance
After 2026-06-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-12 · Grant · Acquired 17,857.143 · Balance 81,141.134 F1: Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1. F2: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan. F3: Holdings include phantom stock acquired in dividend reinvestment transactions on September 11, 2025, December 11, 2025, March 12, 2026 and June 11, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1.
F2: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.
F3: Holdings include phantom stock acquired in dividend reinvestment transactions on September 11, 2025, December 11, 2025, March 12, 2026 and June 11, 2026.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Palo Alto Networks Inc
Report date December 12, 2024 · Filed December 17, 2024
Section 16 reporting ended · disclosed 2024-12-17. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 12, 2026 Filed Jun 15, 2026 20:34 UTC | Organon & Co. OGN · Entity 4115 | GrantPhantom Stock · Derivative | 17,857.143 | $13.44 | $240,000.00 |
DisclosureSEC source: 0001628280-26-043228 · wk-form4_1781555680.xml · derivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,141.134 Underlying: Common Stock · 17,857.143 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1. F2 · derivative.exercise_date: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan. F2 · derivative.expiration_date: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan. F3 · balance_after: Holdings include phantom stock acquired in dividend reinvestment transactions on September 11, 2025, December 11, 2025, March 12, 2026 and June 11, 2026. Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 21:22 UTC | Organon & Co. OGN · Entity 4115 | GrantPhantom Stock · Derivative | 23,904.382 | $10.04 | $240,000.00 |
DisclosureSEC source: 0001821825-25-000047 · wk-form4_1750108969.xml · derivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,702.656 Underlying: Common Stock · 23,904.382 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1. F2 · derivative.exercise_date: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan. F2 · derivative.expiration_date: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan. F3 · balance_after: Holdings include phantom stock units acquired in dividend reinvestment transactions on June 13, 2024, September 12, 2024, December 12, 2024, March 13, 2025 and June 12, 2025. Read SEC document |
| December 10, 2024 Filed Dec 11, 2024 23:48 UTC | Palo Alto Networks Inc PANW · Entity 1811 | GrantCommon Stock | 915 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-135529 · ownership.xml · nonDerivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,050 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal quarterly increments over a one year period, subject to the Reporting Person's continued service as of each such date. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 19:17 UTC | Organon & Co. OGN · Entity 4115 | GrantPhantom Stock · Derivative | 9,638.554 | $20.75 | $200,000.00 |
DisclosureSEC source: 0001821825-24-000077 · wk-form4_1718133442.xml · derivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,454.817 Underlying: Common Stock · 9,638.554 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1. F2 · derivative.exercise_date: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan. F2 · derivative.expiration_date: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan. F3 · balance_after: Holdings include phantom stock acquired in dividend reinvestment transactions on June 15, 2023, September 14, 2023, December 14, 2023 and March 14, 2024. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 16:55 UTC | COCA COLA CO KO · Entity 2806 | GrantPhantom Share Units · Derivative | 3,280.3018 | $60.97 Strike: $0.00 | $200,000.00 |
DisclosureSEC source: 0001127602-24-012078 · form4.xml · derivative · entry 2 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,143.8912 Underlying: Common Stock, $.25 Par Value · 3,280.3018 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom share unit is economically equivalent to one share of Common Stock. F2 · shares: Phantom share units credited to the reporting person under The Coca-Cola Company Directors' Plan effective January 1, 2020 (the "Directors' Plan") for 2024 compensation, which may include voluntary deferred compensation. F3 · derivative.exercise_date: The phantom share units credited under the Directors' Plan are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board. F3 · derivative.expiration_date: The phantom share units credited under the Directors' Plan are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board. F4 · balance_after: This number includes phantom share units accrued through April 1, 2024 under the Directors' Plan as a result of crediting phantom dividends. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 21:41 UTC | Palo Alto Networks Inc PANW · Entity 1811 | GrantCommon Stock | 1,308 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-058494 · doc4.xml · nonDerivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,135 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal quarterly increments over a one year period, subject to the Reporting Person's continued service as of each such date. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 20:53 UTC | Organon & Co. OGN · Entity 4115 | GrantPhantom Stock · Derivative | 10,086 | $19.83 | $200,005.38 |
DisclosureSEC source: 0001209191-23-036774 · doc4.xml · derivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,285 Underlying: Common Stock · 10,086 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1. F2 · derivative.exercise_date: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan. F2 · derivative.expiration_date: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan. F3 · balance_after: Holdings include phantom stock acquired in dividend reinvestment transactions on June 16, 2022, September 15, 2022, December 15, 2022 and March 16, 2023. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 18:13 UTC | COCA COLA CO KO · Entity 2806 | GrantPhantom Share Units · Derivative | 3,222.6877 | $62.06 Strike: $0.00 | $200,000.00 |
DisclosureSEC source: 0001127602-23-012090 · form4.xml · derivative · entry 2 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,626.9716 Underlying: Common Stock, $.25 Par Value · 3,222.6877 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom share unit is economically equivalent to one share of Common Stock. F2 · shares: Phantom share units credited to the reporting person under The Coca-Cola Company Directors' Plan effective January 1, 2020 (the "Directors' Plan") for 2023 compensation, which may include voluntary deferred compensation. F3 · derivative.exercise_date: The phantom share units credited under the Directors' Plan are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board. F3 · derivative.expiration_date: The phantom share units credited under the Directors' Plan are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board. F4 · balance_after: This number includes phantom share units accrued through December 15, 2022 under the Directors' Plan as a result of crediting phantom dividends. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 00:04 UTC | Palo Alto Networks Inc PANW · Entity 1811 | GrantCommon Stock | 2,157 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-061313 · doc4.xml · nonDerivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,827 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal quarterly increments over a one year period, subject to the Reporting Person's continued service as of each such date. F2 · balance_after: The number of shares beneficially owned reflects the Issuer's 3-for-1 stock split effected September 13, 2022. Read SEC document |
| June 10, 2022 Filed Jun 14, 2022 23:37 UTC | Organon & Co. OGN · Entity 4115 | GrantPhantom Stock · Derivative | 5,640 | $35.46 | $199,994.40 |
DisclosureSEC source: 0001104659-22-071138 · tm2218336-6_4seq1.xml · derivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,638 Underlying: Common Stock · 5,640 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1. F2 · derivative.exercise_date: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan. F2 · derivative.expiration_date: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan. F3 · balance_after: Holdings include phantom stock acquired in dividend reinvestment transactions on September 13, 2021, December 16, 2021 and March 17, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 19:11 UTC | COCA COLA CO KO · Entity 2806 | GrantPhantom Share Units · Derivative | 3,198.9763 | $62.52 Strike: $0.00 | $200,000.00 |
DisclosureSEC source: 0001127602-22-011477 · form4.xml · derivative · entry 2 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,284.8982 Underlying: Common Stock, $.25 Par Value · 3,198.9763 shares Expires not disclosed F2 · derivative.exercise_price: Each phantom share unit is economically equivalent to one share of Common Stock. F3 · shares: Phantom share units credited to the reporting person under The Coca-Cola Company Directors' Plan effective January 1, 2020 (the "Directors' Plan") for 2022 compensation, which may include voluntary deferred compensation. F4 · derivative.exercise_date: The phantom share units credited under the Directors' Plan are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board. F4 · derivative.expiration_date: The phantom share units credited under the Directors' Plan are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board. F5 · balance_after: This number includes phantom share units accrued through April 1, 2022 under the Directors' Plan as result of crediting phantom dividends. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 21:25 UTC | GoHealth, Inc. GOCO · Entity 22896 | GrantDeferred Stock Units · Derivative | 5,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001808220-21-000051 · wf-form4_163182748794731.xml · derivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,831 Underlying: Class A Common Stock · 5,688 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Class A common stock of the Issuer. F2 · derivative.exercise_date: The deferred stock units vest in four quarterly installments, with the first such quarterly installment vesting on December 14, 2021, and will be settled in shares of the Issuer's Class A common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Directors Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan. F2 · derivative.expiration_date: The deferred stock units vest in four quarterly installments, with the first such quarterly installment vesting on December 14, 2021, and will be settled in shares of the Issuer's Class A common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Directors Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan. Read SEC document |
| June 04, 2021 Filed Jun 9, 2021 00:32 UTC | Organon & Co. OGN · Entity 4115 | GrantPhantom Stock · Derivative | 8,772 | $36.05 | $316,230.60 |
DisclosureSEC source: 0000899243-21-022671 · doc4.xml · derivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,772 Underlying: Common Stock · 8,772 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Consists of (i) a one-time grant of 5,549 phantom units awarded in connection with the separation of Organon & Co. ("Organon") from Merck & Co., Inc. (the "Separation"), which units will vest in full on the earlier of the one-year anniversary of the Separation or Organon's first annual shareholders meeting after the Separation, and (ii) a pro-rata portion of the annual equity retainer in the form of 3,223 phantom units, which units are fully vested. Phantom units are granted under the Organon Non-Employee Director Savings Plan and are payable in cash upon settlement no sooner than one year after service as a director ceases. F2 · derivative.expiration_date: Consists of (i) a one-time grant of 5,549 phantom units awarded in connection with the separation of Organon & Co. ("Organon") from Merck & Co., Inc. (the "Separation"), which units will vest in full on the earlier of the one-year anniversary of the Separation or Organon's first annual shareholders meeting after the Separation, and (ii) a pro-rata portion of the annual equity retainer in the form of 3,223 phantom units, which units are fully vested. Phantom units are granted under the Organon Non-Employee Director Savings Plan and are payable in cash upon settlement no sooner than one year after service as a director ceases. Read SEC document |
| May 26, 2021 Filed May 28, 2021 20:15 UTC | GoHealth, Inc. GOCO · Entity 22896 | GrantDeferred Stock Units · Derivative | 7,143 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-021104 · doc4.xml · derivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,143 Underlying: Class A Common Stock · 7,143 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Class A common stock of the Issuer. F2 · derivative.exercise_date: The deferred stock units vest in four quarterly installments, with the first such quarterly installment vesting on August 26, 2021, and will be settled in shares of the Issuer's Class A common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Directors Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan. F2 · derivative.expiration_date: The deferred stock units vest in four quarterly installments, with the first such quarterly installment vesting on August 26, 2021, and will be settled in shares of the Issuer's Class A common stock either (i) on a date selected by the reporting person pursuant to the Issuer's Directors Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan. Read SEC document |
| May 25, 2021 Filed May 26, 2021 20:34 UTC | Palo Alto Networks Inc PANW · Entity 1811 | GrantCommon Stock | 2,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-035935 · doc4.xml · nonDerivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,890 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs shall vest over a three year period, with 1/3 of the shares to vest on May 25, 2022 and the remainder to vest in 1/12 increments on each quarterly anniversary thereafter, subject to the Reporting Person's continued service as of each such date. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:24 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 228 | $76.48 | $17,437.44 |
DisclosureSEC source: 0001225208-21-006475 · doc4.xml · nonDerivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,063 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:02 UTC | COCA COLA CO KO · Entity 2806 | GrantPhantom Stock Units · Derivative | 3,787.1615 | $52.81 Strike: $0.00 | $200,000.00 |
DisclosureSEC source: 0001127602-21-013153 · form4.xml · derivative · entry 2 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,649.0912 Underlying: Common Stock, $.25 Par Value · 3,787.1615 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom share unit is economically equivalent to one share of Common Stock. F2 · shares: Phantom share units credited to the reporting person under The Coca-Cola Company Directors' Plan effective January 1, 2020 (the "Directors' Plan") for 2021 compensation, which may include voluntary deferred compensation. F3 · derivative.exercise_date: The phantom share units credited under the Directors' Plan are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board. F3 · derivative.expiration_date: The phantom share units credited under the Directors' Plan are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board. F4 · balance_after: This number includes phantom share units accrued through April 1, 2021 under the Directors' Plan as result of crediting phantom dividends. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:38 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 205 | $85.10 | $17,445.50 |
DisclosureSEC source: 0001225208-21-000327 · doc4.xml · nonDerivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,747 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 21:10 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 228 | $76.68 | $17,483.04 |
DisclosureSEC source: 0001225208-20-012213 · doc4.xml · nonDerivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,461 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| July 15, 2020 Filed Jul 17, 2020 20:30 UTC | GoHealth, Inc. GOCO · Entity 22896 | GrantClass A Common Stock | 7,143 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-019530 · doc4.xml · nonDerivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,143 F1 · shares: Represents a grant of restricted stock units which vest in four equal quarterly installments, with the first such quarterly installment vesting on October 15, 2020. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:46 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 240 | $72.82 | $17,476.80 |
DisclosureSEC source: 0001225208-20-009510 · doc4.xml · nonDerivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,147 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:35 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantStock Option (Right to Buy) · Derivative | 4,155 | $0.00 Strike: $69.83 | $0.00 |
DisclosureSEC source: 0001225208-20-007606 · doc4.xml · derivative · entry 3 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,155 Underlying: Common Stock · 4,155 shares Expires 2028-05-11 F2 · kind: Annual director stock option grant under the issuer's incentive compensation plan. F3 · derivative.exercise_date: Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2020 grant date. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:35 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 2,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-007606 · doc4.xml · nonDerivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,837 F1 · kind: Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 21:56 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 260 | $67.31 | $17,500.60 |
DisclosureSEC source: 0001225208-20-006069 · doc4.xml · nonDerivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,221 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 19:10 UTC | COCA COLA CO KO · Entity 2806 | GrantPhantom Stock Units · Derivative | 4,680.5523 | $42.73 Strike: $0.00 | $200,000.00 |
DisclosureSEC source: 0001127602-20-013015 · form4.xml · derivative · entry 2 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,447.4586 Underlying: Common Stock, $.25 Par Value · 4,680.5523 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom share unit is economically equivalent to one share of Common Stock. F2 · shares: Phantom share units credited to the reporting person under The Coca-Cola Company Directors' Plan effective January 1, 2020 (the "Directors' Plan") for 2020 compensation, which may include voluntary deferred compensation. F3 · derivative.exercise_date: The phantom share units credited under the Directors' Plan are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board. F3 · derivative.expiration_date: The phantom share units credited under the Directors' Plan are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board. F4 · balance_after: This number includes phantom share units accrued through April 1, 2020 under the Directors' Plan as result of crediting phantom dividends. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 21:53 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,802 | $0.00 Strike: $71.65 | $0.00 |
DisclosureSEC source: 0001225208-20-001940 · doc4.xml · derivative · entry 12 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,901 Underlying: Common Stock · 3,802 shares Expires 2023-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan. F8 · derivative.exercise_date: Option became exercisable in one-third increments beginning on the first anniversary of the May 15, 2017 grant date. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 21:53 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,109 | $0.00 Strike: $62.04 | $0.00 |
DisclosureSEC source: 0001225208-20-001940 · doc4.xml · derivative · entry 11 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,220 Underlying: Common Stock · 2,109 shares Expires 2024-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan. F7 · derivative.exercise_date: Option became exercisable in one-third increments beginning on the first anniversary of the May 14, 2018 grant date. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 21:53 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,357 | $0.00 Strike: $67.19 | $0.00 |
DisclosureSEC source: 0001225208-20-001940 · doc4.xml · derivative · entry 10 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,357 shares Expires 2020-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan. F6 · derivative.exercise_date: Option became exercisable in one-third increments beginning on the first anniversary of the May 12, 2014 grant date. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 21:53 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,583 | $0.00 Strike: $67.83 | $0.00 |
DisclosureSEC source: 0001225208-20-001940 · doc4.xml · derivative · entry 9 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,583 shares Expires 2021-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan. F5 · derivative.exercise_date: Option became exercisable in one-third increments beginning on the first anniversary of the May, 11, 2015 grant date. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 21:53 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,389 | $0.00 Strike: $71.76 | $0.00 |
DisclosureSEC source: 0001225208-20-001940 · doc4.xml · derivative · entry 8 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,389 shares Expires 2022-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan. F4 · derivative.exercise_date: Option became exercisable in one-third increments beginning on the first anniversary of the May 9, 2016 grant date. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 21:53 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | SaleCommon Stock | 22,240 | $76.08 | $1,692,128.18 |
DisclosureSEC source: 0001225208-20-001940 · doc4.xml · nonDerivative · entry 6 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,890 F2 · kind: Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan. F3 · price: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $76.03 to $76.13, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 21:53 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Exercise / conversionCommon Stock | 2,109 | $62.04 | $130,842.36 |
DisclosureSEC source: 0001225208-20-001940 · doc4.xml · nonDerivative · entry 5 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 21:53 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Exercise / conversionCommon Stock | 3,802 | $71.65 | $272,413.30 |
DisclosureSEC source: 0001225208-20-001940 · doc4.xml · nonDerivative · entry 4 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,021 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 21:53 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Exercise / conversionCommon Stock | 5,357 | $67.19 | $359,936.83 |
DisclosureSEC source: 0001225208-20-001940 · doc4.xml · nonDerivative · entry 3 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 21:53 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Exercise / conversionCommon Stock | 5,389 | $71.76 | $386,714.64 |
DisclosureSEC source: 0001225208-20-001940 · doc4.xml · nonDerivative · entry 2 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,862 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 21:53 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Exercise / conversionCommon Stock | 5,583 | $67.83 | $378,694.89 |
DisclosureSEC source: 0001225208-20-001940 · doc4.xml · nonDerivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:25 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 256 | $68.25 | $17,472.00 |
DisclosureSEC source: 0001225208-20-000553 · doc4.xml · nonDerivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,890 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 21:55 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 241 | $72.44 | $17,458.04 |
DisclosureSEC source: 0001225208-19-013193 · doc4.xml · nonDerivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,562 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 21:05 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 240 | $72.67 | $17,440.80 |
DisclosureSEC source: 0001225208-19-010058 · doc4.xml · nonDerivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,389 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 13, 2019 Filed May 15, 2019 20:33 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantStock Option (Right to Buy) · Derivative | 4,170 | $0.00 Strike: $71.56 | $0.00 |
DisclosureSEC source: 0001225208-19-008058 · doc4.xml · derivative · entry 2 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,170 Underlying: Common Stock · 4,170 shares Expires 2027-05-13 F2 · kind: Annual director stock option grant under the issuer's incentive compensation plan. F3 · derivative.exercise_date: Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 13, 2019 grant date. Read SEC document |
| May 13, 2019 Filed May 15, 2019 20:33 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 2,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-008058 · doc4.xml · nonDerivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,084 F1 · kind: Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan. Read SEC document |
| May 03, 2019 Filed May 7, 2019 22:31 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,780 | $0.00 Strike: $60.45 | $0.00 |
DisclosureSEC source: 0001223203-19-000021 · primary_doc.xml · derivative · entry 3 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,780 shares Expires 2019-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of stock options granted under the issuer's incentive compensation plan. F4 · derivative.exercise_date: Option became exercisable in one-third increments beginning on the first anniversary of the May 13, 2013 grant date. Read SEC document |
| May 03, 2019 Filed May 7, 2019 22:31 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | SaleCommon Stock | 5,780 | $71.95 | $415,846.15 |
DisclosureSEC source: 0001223203-19-000021 · primary_doc.xml · nonDerivative · entry 2 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,569 F2 · kind: Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan. F3 · price: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $71.89 to $72.02, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 03, 2019 Filed May 7, 2019 22:31 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | Exercise / conversionCommon Stock | 5,780 | $60.45 | $349,401.00 |
DisclosureSEC source: 0001223203-19-000021 · primary_doc.xml · nonDerivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,349 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of stock options granted under the issuer's incentive compensation plan. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:51 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 264 | $66.22 | $17,482.08 |
DisclosureSEC source: 0001225208-19-006348 · doc4.xml · nonDerivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,569 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:47 UTC | COCA COLA CO KO · Entity 2806 | GrantPhantom Stock Units · Derivative | 4,266.2116 | $46.88 Strike: $0.00 | $200,000.00 |
DisclosureSEC source: 0001127602-19-014650 · form4.xml · derivative · entry 2 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,567.0822 Underlying: Common Stock, $.25 Par Value · 4,266.2116 shares Expires not disclosed F2 · derivative.exercise_price: Each phantom share unit is economically equivalent to one share of Common Stock. F3 · shares: Phantom share units credited to the reporting person under The Coca-Cola Company Directors' Plan effective January 1, 2013 (the "Directors' Plan") for 2019 compensation, which may include voluntary deferred compensation. F4 · derivative.exercise_date: The phantom share units credited under The Coca-Cola Company Directors' Plan effective January 1, 2013 (the "Directors' Plan") are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board. F4 · derivative.expiration_date: The phantom share units credited under The Coca-Cola Company Directors' Plan effective January 1, 2013 (the "Directors' Plan") are settled in cash the later of (i) January 15 of the year following the year in which the reporting person leaves the Board, or (ii) six months following the date on which the reporting person leaves the Board. F5 · balance_after: This number includes phantom share units accrued through April 1, 2019 under the Directors' Plan as result of crediting phantom dividends. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 22:08 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 281 | $62.24 | $17,489.44 |
DisclosureSEC source: 0001225208-19-000454 · doc4.xml · nonDerivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,254 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 20:27 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 259 | $67.53 | $17,490.27 |
DisclosureSEC source: 0001225208-18-014327 · doc4.xml · nonDerivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,922 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 21:20 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 274 | $63.76 | $17,470.24 |
DisclosureSEC source: 0001225208-18-011356 · doc4.xml · nonDerivative · entry 1 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,616 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 14, 2018 Filed May 16, 2018 20:42 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantStock Option (Right to Buy) · Derivative | 6,329 | $0.00 Strike: $62.04 | $0.00 |
DisclosureSEC source: 0001225208-18-009467 · doc4.xml · derivative · entry 2 Gayle Helene D · CIK 0001487047 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,329 Underlying: Common Stock · 6,329 shares Expires 2024-05-14 F2 · kind: Annual director stock option grant under the issuer's incentive compensation plan. F3 · derivative.exercise_date: Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 14, 2018 grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.